Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostanoids in the therapy of glaucoma.
Ishida N, Odani-Kawabata N, Shimazaki A, Hara H. Ishida N, et al. Cardiovasc Drug Rev. 2006 Spring;24(1):1-10. doi: 10.1111/j.1527-3466.2006.00001.x. Cardiovasc Drug Rev. 2006. PMID: 16939629 Review.
Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
Aihara M, Lu F, Kawata H, Tanaka Y, Yamamura K, Odani-Kawabata N, Shams NK. Aihara M, et al. J Ocul Pharmacol Ther. 2019 Dec;35(10):542-550. doi: 10.1089/jop.2019.0044. Epub 2019 Nov 1. J Ocul Pharmacol Ther. 2019. PMID: 31674861 Free PMC article. Clinical Trial.
24 results